0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cisatracurium Besylate Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-34Y7616
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Cisatracurium Besylate Market Insights and Forecast to 2028
BUY CHAPTERS

Global Cisatracurium Besylate Market Research Report 2025

Code: QYRE-Auto-34Y7616
Report
July 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cisatracurium Besylate Market

The global market for Cisatracurium Besylate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Cisatracurium besylate is the latest generation of muscle relaxant. Compared with the major clinical muscle relaxants, this product has the characteristics of metabolism through non-hepatic and non-renal pathways and cardiovascular stability.Atracurium is mainly used in general anesthesia, and can be widely used in endotracheal intubation, liver and kidney dysfunction, cardiovascular surgery and elderly and pediatric patients.Since the drug was first marketed in the UK in 1996, it has gradually replaced vecuronium bromide and atracurium in foreign countries and become the mainstream of clinical muscle relaxants.
North American market for Cisatracurium Besylate is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cisatracurium Besylate is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Cisatracurium Besylate include GSK, Aspen Pharmacare, AbbVie, Abbott, Pfizer, Mylan Pharmaceuticals, Fresenius Kabi, Omega Laboratories Ltd, Somerset Therapeutics, Jiangsu Hengrui Medicine, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cisatracurium Besylate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cisatracurium Besylate.
The Cisatracurium Besylate market size, estimations, and forecasts are provided in terms of sales volume (Litre) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cisatracurium Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cisatracurium Besylate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Cisatracurium Besylate Market Report

Report Metric Details
Report Name Cisatracurium Besylate Market
Segment by Type
  • Solution
  • Injection
Segment by Application
  • General Anesthesia
  • Endotracheal Intubation
  • Liver And Kidney Dysfunction
  • Cardiovascular Surgery
  • Old Families
  • Pediatric
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GSK, Aspen Pharmacare, AbbVie, Abbott, Pfizer, Mylan Pharmaceuticals, Fresenius Kabi, Omega Laboratories Ltd, Somerset Therapeutics, Jiangsu Hengrui Medicine, Shanghai Pharmaceuticals Holding, Zhejiang Xianju
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Cisatracurium Besylate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Cisatracurium Besylate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Cisatracurium Besylate Market report?

Ans: The main players in the Cisatracurium Besylate Market are GSK, Aspen Pharmacare, AbbVie, Abbott, Pfizer, Mylan Pharmaceuticals, Fresenius Kabi, Omega Laboratories Ltd, Somerset Therapeutics, Jiangsu Hengrui Medicine, Shanghai Pharmaceuticals Holding, Zhejiang Xianju

What are the Application segmentation covered in the Cisatracurium Besylate Market report?

Ans: The Applications covered in the Cisatracurium Besylate Market report are General Anesthesia, Endotracheal Intubation, Liver And Kidney Dysfunction, Cardiovascular Surgery, Old Families, Pediatric, Other

What are the Type segmentation covered in the Cisatracurium Besylate Market report?

Ans: The Types covered in the Cisatracurium Besylate Market report are Solution, Injection

1 Cisatracurium Besylate Market Overview
1.1 Product Definition
1.2 Cisatracurium Besylate by Type
1.2.1 Global Cisatracurium Besylate Market Value Comparison by Type (2024 VS 2031)
1.2.2 Solution
1.2.3 Injection
1.3 Cisatracurium Besylate by Application
1.3.1 Global Cisatracurium Besylate Market Value by Application (2024 VS 2031)
1.3.2 General Anesthesia
1.3.3 Endotracheal Intubation
1.3.4 Liver And Kidney Dysfunction
1.3.5 Cardiovascular Surgery
1.3.6 Old Families
1.3.7 Pediatric
1.3.8 Other
1.4 Global Cisatracurium Besylate Market Size Estimates and Forecasts
1.4.1 Global Cisatracurium Besylate Revenue 2020-2031
1.4.2 Global Cisatracurium Besylate Sales 2020-2031
1.4.3 Global Cisatracurium Besylate Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Cisatracurium Besylate Market Competition by Manufacturers
2.1 Global Cisatracurium Besylate Sales Market Share by Manufacturers (2020-2025)
2.2 Global Cisatracurium Besylate Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Cisatracurium Besylate Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Cisatracurium Besylate, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cisatracurium Besylate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cisatracurium Besylate, Product Type & Application
2.7 Global Key Manufacturers of Cisatracurium Besylate, Date of Enter into This Industry
2.8 Global Cisatracurium Besylate Market Competitive Situation and Trends
2.8.1 Global Cisatracurium Besylate Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Cisatracurium Besylate Players Market Share by Revenue
2.8.3 Global Cisatracurium Besylate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cisatracurium Besylate Market Scenario by Region
3.1 Global Cisatracurium Besylate Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Cisatracurium Besylate Sales by Region: 2020-2031
3.2.1 Global Cisatracurium Besylate Sales by Region: 2020-2025
3.2.2 Global Cisatracurium Besylate Sales by Region: 2026-2031
3.3 Global Cisatracurium Besylate Revenue by Region: 2020-2031
3.3.1 Global Cisatracurium Besylate Revenue by Region: 2020-2025
3.3.2 Global Cisatracurium Besylate Revenue by Region: 2026-2031
3.4 North America Cisatracurium Besylate Market Facts & Figures by Country
3.4.1 North America Cisatracurium Besylate Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Cisatracurium Besylate Sales by Country (2020-2031)
3.4.3 North America Cisatracurium Besylate Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cisatracurium Besylate Market Facts & Figures by Country
3.5.1 Europe Cisatracurium Besylate Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Cisatracurium Besylate Sales by Country (2020-2031)
3.5.3 Europe Cisatracurium Besylate Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cisatracurium Besylate Market Facts & Figures by Region
3.6.1 Asia Pacific Cisatracurium Besylate Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Cisatracurium Besylate Sales by Region (2020-2031)
3.6.3 Asia Pacific Cisatracurium Besylate Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cisatracurium Besylate Market Facts & Figures by Country
3.7.1 Latin America Cisatracurium Besylate Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Cisatracurium Besylate Sales by Country (2020-2031)
3.7.3 Latin America Cisatracurium Besylate Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cisatracurium Besylate Market Facts & Figures by Country
3.8.1 Middle East and Africa Cisatracurium Besylate Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Cisatracurium Besylate Sales by Country (2020-2031)
3.8.3 Middle East and Africa Cisatracurium Besylate Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cisatracurium Besylate Sales by Type (2020-2031)
4.1.1 Global Cisatracurium Besylate Sales by Type (2020-2025)
4.1.2 Global Cisatracurium Besylate Sales by Type (2026-2031)
4.1.3 Global Cisatracurium Besylate Sales Market Share by Type (2020-2031)
4.2 Global Cisatracurium Besylate Revenue by Type (2020-2031)
4.2.1 Global Cisatracurium Besylate Revenue by Type (2020-2025)
4.2.2 Global Cisatracurium Besylate Revenue by Type (2026-2031)
4.2.3 Global Cisatracurium Besylate Revenue Market Share by Type (2020-2031)
4.3 Global Cisatracurium Besylate Price by Type (2020-2031)
5 Segment by Application
5.1 Global Cisatracurium Besylate Sales by Application (2020-2031)
5.1.1 Global Cisatracurium Besylate Sales by Application (2020-2025)
5.1.2 Global Cisatracurium Besylate Sales by Application (2026-2031)
5.1.3 Global Cisatracurium Besylate Sales Market Share by Application (2020-2031)
5.2 Global Cisatracurium Besylate Revenue by Application (2020-2031)
5.2.1 Global Cisatracurium Besylate Revenue by Application (2020-2025)
5.2.2 Global Cisatracurium Besylate Revenue by Application (2026-2031)
5.2.3 Global Cisatracurium Besylate Revenue Market Share by Application (2020-2031)
5.3 Global Cisatracurium Besylate Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Company Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Cisatracurium Besylate Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GSK Cisatracurium Besylate Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Aspen Pharmacare
6.2.1 Aspen Pharmacare Company Information
6.2.2 Aspen Pharmacare Description and Business Overview
6.2.3 Aspen Pharmacare Cisatracurium Besylate Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Aspen Pharmacare Cisatracurium Besylate Product Portfolio
6.2.5 Aspen Pharmacare Recent Developments/Updates
6.3 AbbVie
6.3.1 AbbVie Company Information
6.3.2 AbbVie Description and Business Overview
6.3.3 AbbVie Cisatracurium Besylate Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AbbVie Cisatracurium Besylate Product Portfolio
6.3.5 AbbVie Recent Developments/Updates
6.4 Abbott
6.4.1 Abbott Company Information
6.4.2 Abbott Description and Business Overview
6.4.3 Abbott Cisatracurium Besylate Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Abbott Cisatracurium Besylate Product Portfolio
6.4.5 Abbott Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Company Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Cisatracurium Besylate Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Pfizer Cisatracurium Besylate Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Mylan Pharmaceuticals
6.6.1 Mylan Pharmaceuticals Company Information
6.6.2 Mylan Pharmaceuticals Description and Business Overview
6.6.3 Mylan Pharmaceuticals Cisatracurium Besylate Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Mylan Pharmaceuticals Cisatracurium Besylate Product Portfolio
6.6.5 Mylan Pharmaceuticals Recent Developments/Updates
6.7 Fresenius Kabi
6.7.1 Fresenius Kabi Company Information
6.7.2 Fresenius Kabi Description and Business Overview
6.7.3 Fresenius Kabi Cisatracurium Besylate Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Fresenius Kabi Cisatracurium Besylate Product Portfolio
6.7.5 Fresenius Kabi Recent Developments/Updates
6.8 Omega Laboratories Ltd
6.8.1 Omega Laboratories Ltd Company Information
6.8.2 Omega Laboratories Ltd Description and Business Overview
6.8.3 Omega Laboratories Ltd Cisatracurium Besylate Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Omega Laboratories Ltd Cisatracurium Besylate Product Portfolio
6.8.5 Omega Laboratories Ltd Recent Developments/Updates
6.9 Somerset Therapeutics
6.9.1 Somerset Therapeutics Company Information
6.9.2 Somerset Therapeutics Description and Business Overview
6.9.3 Somerset Therapeutics Cisatracurium Besylate Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Somerset Therapeutics Cisatracurium Besylate Product Portfolio
6.9.5 Somerset Therapeutics Recent Developments/Updates
6.10 Jiangsu Hengrui Medicine
6.10.1 Jiangsu Hengrui Medicine Company Information
6.10.2 Jiangsu Hengrui Medicine Description and Business Overview
6.10.3 Jiangsu Hengrui Medicine Cisatracurium Besylate Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Jiangsu Hengrui Medicine Cisatracurium Besylate Product Portfolio
6.10.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.11 Shanghai Pharmaceuticals Holding
6.11.1 Shanghai Pharmaceuticals Holding Company Information
6.11.2 Shanghai Pharmaceuticals Holding Description and Business Overview
6.11.3 Shanghai Pharmaceuticals Holding Cisatracurium Besylate Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Shanghai Pharmaceuticals Holding Cisatracurium Besylate Product Portfolio
6.11.5 Shanghai Pharmaceuticals Holding Recent Developments/Updates
6.12 Zhejiang Xianju
6.12.1 Zhejiang Xianju Company Information
6.12.2 Zhejiang Xianju Description and Business Overview
6.12.3 Zhejiang Xianju Cisatracurium Besylate Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Zhejiang Xianju Cisatracurium Besylate Product Portfolio
6.12.5 Zhejiang Xianju Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cisatracurium Besylate Industry Chain Analysis
7.2 Cisatracurium Besylate Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cisatracurium Besylate Production Mode & Process Analysis
7.4 Cisatracurium Besylate Sales and Marketing
7.4.1 Cisatracurium Besylate Sales Channels
7.4.2 Cisatracurium Besylate Distributors
7.5 Cisatracurium Besylate Customer Analysis
8 Cisatracurium Besylate Market Dynamics
8.1 Cisatracurium Besylate Industry Trends
8.2 Cisatracurium Besylate Market Drivers
8.3 Cisatracurium Besylate Market Challenges
8.4 Cisatracurium Besylate Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Cisatracurium Besylate Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Cisatracurium Besylate Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Cisatracurium Besylate Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Cisatracurium Besylate Sales (Litre) of Key Manufacturers (2020-2025)
 Table 5. Global Cisatracurium Besylate Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Cisatracurium Besylate Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Cisatracurium Besylate Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Cisatracurium Besylate Average Price (US$/ML) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Cisatracurium Besylate, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Cisatracurium Besylate, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Cisatracurium Besylate, Product Type & Application
 Table 12. Global Key Manufacturers of Cisatracurium Besylate, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Cisatracurium Besylate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cisatracurium Besylate as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Cisatracurium Besylate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Cisatracurium Besylate Sales by Region (2020-2025) & (Litre)
 Table 18. Global Cisatracurium Besylate Sales Market Share by Region (2020-2025)
 Table 19. Global Cisatracurium Besylate Sales by Region (2026-2031) & (Litre)
 Table 20. Global Cisatracurium Besylate Sales Market Share by Region (2026-2031)
 Table 21. Global Cisatracurium Besylate Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Cisatracurium Besylate Revenue Market Share by Region (2020-2025)
 Table 23. Global Cisatracurium Besylate Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Cisatracurium Besylate Revenue Market Share by Region (2026-2031)
 Table 25. North America Cisatracurium Besylate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Cisatracurium Besylate Sales by Country (2020-2025) & (Litre)
 Table 27. North America Cisatracurium Besylate Sales by Country (2026-2031) & (Litre)
 Table 28. North America Cisatracurium Besylate Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Cisatracurium Besylate Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Cisatracurium Besylate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Cisatracurium Besylate Sales by Country (2020-2025) & (Litre)
 Table 32. Europe Cisatracurium Besylate Sales by Country (2026-2031) & (Litre)
 Table 33. Europe Cisatracurium Besylate Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Cisatracurium Besylate Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Cisatracurium Besylate Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Cisatracurium Besylate Sales by Region (2020-2025) & (Litre)
 Table 37. Asia Pacific Cisatracurium Besylate Sales by Region (2026-2031) & (Litre)
 Table 38. Asia Pacific Cisatracurium Besylate Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Cisatracurium Besylate Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Cisatracurium Besylate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Cisatracurium Besylate Sales by Country (2020-2025) & (Litre)
 Table 42. Latin America Cisatracurium Besylate Sales by Country (2026-2031) & (Litre)
 Table 43. Latin America Cisatracurium Besylate Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Cisatracurium Besylate Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Cisatracurium Besylate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Cisatracurium Besylate Sales by Country (2020-2025) & (Litre)
 Table 47. Middle East and Africa Cisatracurium Besylate Sales by Country (2026-2031) & (Litre)
 Table 48. Middle East and Africa Cisatracurium Besylate Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Cisatracurium Besylate Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Cisatracurium Besylate Sales (Litre) by Type (2020-2025)
 Table 51. Global Cisatracurium Besylate Sales (Litre) by Type (2026-2031)
 Table 52. Global Cisatracurium Besylate Sales Market Share by Type (2020-2025)
 Table 53. Global Cisatracurium Besylate Sales Market Share by Type (2026-2031)
 Table 54. Global Cisatracurium Besylate Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Cisatracurium Besylate Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Cisatracurium Besylate Revenue Market Share by Type (2020-2025)
 Table 57. Global Cisatracurium Besylate Revenue Market Share by Type (2026-2031)
 Table 58. Global Cisatracurium Besylate Price (US$/ML) by Type (2020-2025)
 Table 59. Global Cisatracurium Besylate Price (US$/ML) by Type (2026-2031)
 Table 60. Global Cisatracurium Besylate Sales (Litre) by Application (2020-2025)
 Table 61. Global Cisatracurium Besylate Sales (Litre) by Application (2026-2031)
 Table 62. Global Cisatracurium Besylate Sales Market Share by Application (2020-2025)
 Table 63. Global Cisatracurium Besylate Sales Market Share by Application (2026-2031)
 Table 64. Global Cisatracurium Besylate Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Cisatracurium Besylate Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Cisatracurium Besylate Revenue Market Share by Application (2020-2025)
 Table 67. Global Cisatracurium Besylate Revenue Market Share by Application (2026-2031)
 Table 68. Global Cisatracurium Besylate Price (US$/ML) by Application (2020-2025)
 Table 69. Global Cisatracurium Besylate Price (US$/ML) by Application (2026-2031)
 Table 70. GSK Company Information
 Table 71. GSK Description and Business Overview
 Table 72. GSK Cisatracurium Besylate Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2020-2025)
 Table 73. GSK Cisatracurium Besylate Product
 Table 74. GSK Recent Developments/Updates
 Table 75. Aspen Pharmacare Company Information
 Table 76. Aspen Pharmacare Description and Business Overview
 Table 77. Aspen Pharmacare Cisatracurium Besylate Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2020-2025)
 Table 78. Aspen Pharmacare Cisatracurium Besylate Product
 Table 79. Aspen Pharmacare Recent Developments/Updates
 Table 80. AbbVie Company Information
 Table 81. AbbVie Description and Business Overview
 Table 82. AbbVie Cisatracurium Besylate Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2020-2025)
 Table 83. AbbVie Cisatracurium Besylate Product
 Table 84. AbbVie Recent Developments/Updates
 Table 85. Abbott Company Information
 Table 86. Abbott Description and Business Overview
 Table 87. Abbott Cisatracurium Besylate Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2020-2025)
 Table 88. Abbott Cisatracurium Besylate Product
 Table 89. Abbott Recent Developments/Updates
 Table 90. Pfizer Company Information
 Table 91. Pfizer Description and Business Overview
 Table 92. Pfizer Cisatracurium Besylate Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2020-2025)
 Table 93. Pfizer Cisatracurium Besylate Product
 Table 94. Pfizer Recent Developments/Updates
 Table 95. Mylan Pharmaceuticals Company Information
 Table 96. Mylan Pharmaceuticals Description and Business Overview
 Table 97. Mylan Pharmaceuticals Cisatracurium Besylate Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2020-2025)
 Table 98. Mylan Pharmaceuticals Cisatracurium Besylate Product
 Table 99. Mylan Pharmaceuticals Recent Developments/Updates
 Table 100. Fresenius Kabi Company Information
 Table 101. Fresenius Kabi Description and Business Overview
 Table 102. Fresenius Kabi Cisatracurium Besylate Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2020-2025)
 Table 103. Fresenius Kabi Cisatracurium Besylate Product
 Table 104. Fresenius Kabi Recent Developments/Updates
 Table 105. Omega Laboratories Ltd Company Information
 Table 106. Omega Laboratories Ltd Description and Business Overview
 Table 107. Omega Laboratories Ltd Cisatracurium Besylate Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2020-2025)
 Table 108. Omega Laboratories Ltd Cisatracurium Besylate Product
 Table 109. Omega Laboratories Ltd Recent Developments/Updates
 Table 110. Somerset Therapeutics Company Information
 Table 111. Somerset Therapeutics Description and Business Overview
 Table 112. Somerset Therapeutics Cisatracurium Besylate Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2020-2025)
 Table 113. Somerset Therapeutics Cisatracurium Besylate Product
 Table 114. Somerset Therapeutics Recent Developments/Updates
 Table 115. Jiangsu Hengrui Medicine Company Information
 Table 116. Jiangsu Hengrui Medicine Description and Business Overview
 Table 117. Jiangsu Hengrui Medicine Cisatracurium Besylate Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2020-2025)
 Table 118. Jiangsu Hengrui Medicine Cisatracurium Besylate Product
 Table 119. Jiangsu Hengrui Medicine Recent Developments/Updates
 Table 120. Shanghai Pharmaceuticals Holding Company Information
 Table 121. Shanghai Pharmaceuticals Holding Description and Business Overview
 Table 122. Shanghai Pharmaceuticals Holding Cisatracurium Besylate Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2020-2025)
 Table 123. Shanghai Pharmaceuticals Holding Cisatracurium Besylate Product
 Table 124. Shanghai Pharmaceuticals Holding Recent Developments/Updates
 Table 125. Zhejiang Xianju Company Information
 Table 126. Zhejiang Xianju Description and Business Overview
 Table 127. Zhejiang Xianju Cisatracurium Besylate Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2020-2025)
 Table 128. Zhejiang Xianju Cisatracurium Besylate Product
 Table 129. Zhejiang Xianju Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Cisatracurium Besylate Distributors List
 Table 133. Cisatracurium Besylate Customers List
 Table 134. Cisatracurium Besylate Market Trends
 Table 135. Cisatracurium Besylate Market Drivers
 Table 136. Cisatracurium Besylate Market Challenges
 Table 137. Cisatracurium Besylate Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Cisatracurium Besylate
 Figure 2. Global Cisatracurium Besylate Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cisatracurium Besylate Market Share by Type: 2024 & 2031
 Figure 4. Solution Product Picture
 Figure 5. Injection Product Picture
 Figure 6. Global Cisatracurium Besylate Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Cisatracurium Besylate Market Share by Application: 2024 & 2031
 Figure 8. General Anesthesia
 Figure 9. Endotracheal Intubation
 Figure 10. Liver And Kidney Dysfunction
 Figure 11. Cardiovascular Surgery
 Figure 12. Old Families
 Figure 13. Pediatric
 Figure 14. Other
 Figure 15. Global Cisatracurium Besylate Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Cisatracurium Besylate Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Cisatracurium Besylate Sales (2020-2031) & (Litre)
 Figure 18. Global Cisatracurium Besylate Average Price (US$/ML) & (2020-2031)
 Figure 19. Cisatracurium Besylate Report Years Considered
 Figure 20. Cisatracurium Besylate Sales Share by Manufacturers in 2024
 Figure 21. Global Cisatracurium Besylate Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Cisatracurium Besylate Players: Market Share by Revenue in Cisatracurium Besylate in 2024
 Figure 23. Cisatracurium Besylate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Cisatracurium Besylate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Cisatracurium Besylate Sales Market Share by Country (2020-2031)
 Figure 26. North America Cisatracurium Besylate Revenue Market Share by Country (2020-2031)
 Figure 27. U.S. Cisatracurium Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Cisatracurium Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Cisatracurium Besylate Sales Market Share by Country (2020-2031)
 Figure 30. Europe Cisatracurium Besylate Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Cisatracurium Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Cisatracurium Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Cisatracurium Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Cisatracurium Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Cisatracurium Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Cisatracurium Besylate Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Cisatracurium Besylate Revenue Market Share by Region (2020-2031)
 Figure 38. China Cisatracurium Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Cisatracurium Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Cisatracurium Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Cisatracurium Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Cisatracurium Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Taiwan Cisatracurium Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Cisatracurium Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Cisatracurium Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Cisatracurium Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Philippines Cisatracurium Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Latin America Cisatracurium Besylate Sales Market Share by Country (2020-2031)
 Figure 49. Latin America Cisatracurium Besylate Revenue Market Share by Country (2020-2031)
 Figure 50. Mexico Cisatracurium Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Brazil Cisatracurium Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Argentina Cisatracurium Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Middle East and Africa Cisatracurium Besylate Sales Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Cisatracurium Besylate Revenue Market Share by Country (2020-2031)
 Figure 55. Turkey Cisatracurium Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Saudi Arabia Cisatracurium Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. UAE Cisatracurium Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Global Sales Market Share of Cisatracurium Besylate by Type (2020-2031)
 Figure 59. Global Revenue Market Share of Cisatracurium Besylate by Type (2020-2031)
 Figure 60. Global Cisatracurium Besylate Price (US$/ML) by Type (2020-2031)
 Figure 61. Global Sales Market Share of Cisatracurium Besylate by Application (2020-2031)
 Figure 62. Global Revenue Market Share of Cisatracurium Besylate by Application (2020-2031)
 Figure 63. Global Cisatracurium Besylate Price (US$/ML) by Application (2020-2031)
 Figure 64. Cisatracurium Besylate Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS